http://www.zibb.com/healthcare/theme/cq/Bristol+Myers+Squibb+Company Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Wed, 06 May 2009 12:00:00 GMTWed, 06 May 2009 12:00:00 GMT608831http://www.zibb.com/healthcare/theme/cq/Bristol+Myers+Squibb+Company http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.fda.gov/cder/pediatric/exgrant.htmThis list simply identifies approved active moieties with sponsors to which FDA has granted exclusivity for pediatric studies. Only applications held by the identified sponsor were granted pediatric exclusivity.http://www.fda.gov/cder/pediatric/exgrant.htmBristol Myers Squibb CompanyWed, 06 May 2009 12:00:00 GMThttp://www.securethefuture.com/In the fight against HIV/AIDS in Africa, SECURE THE FUTURE® is putting the children first. The Baylor-Bristol-Myers Squibb Children’s Clinical Center of Excellence–Swaziland, which is the third of five planned African clinical centers for children with HIV/AIDS, opened in February.http://www.securethefuture.com/Bristol Myers Squibb Companyhttp://www.pharmaceutical-technology.com/projects/bristolmyerssquibb/In 2006 Bristol-Myers Squibb announced a major investment of $220m (€176m) for the expansion of its biologics manufacturing plant in Manatí, Puerto Rico. The company has four plants in Puerto Rico in total.http://www.pharmaceutical-technology.com/projects/bristolmyerssquibb/Bristol Myers Squibb CompanyThu, 31 Jan 2008 00:00:00 GMThttp://www.bristolmyerssquibb.com/research/disease_areas/content/data/thrombosis.htmlCardiovascular disease is the leading cause of death in the developed world and has been for decades. Nearly 2,500 Americans die of cardiovascular disease each day, an average of one death every 35 seconds.http://www.bristolmyerssquibb.com/research/disease_areas/content/data/thrombosis.htmlBristol Myers Squibb Companyhttp://www.thestreet.com/_yahoo/video/cramermarketupdates/10432793.html?cm_ven=YAHOOV&cm_cat=FREE&cm_ite=NAJim Cramer discusses Bristol-Myers Squibb and Imclone's battle for Erbitux and who will be THE cancer drug company.http://www.thestreet.com/_yahoo/video/cramermarketupdates/10432793.html?cm_ven=YAHOOV&cm_cat=FREE&cm_ite=NABristol Myers Squibb CompanyMon, 11 Aug 2008 16:53:25 GMThttp://www.bms.com/sr/content/data/medical.htmlThe Medical Grants page has moved to: http://www.bms.com/sr/medical_grants/. Please update your links and bookmarks.http://www.bms.com/sr/content/data/medical.htmlBristol Myers Squibb Companyhttp://www.apria.com/resources/1,2725,494-857391,00.htmlDapagliflozin, which is one of two investigational drugs under joint development by the companies, is currently being studied in Phase III clinical trials in several countries, including the US, to assess its efficacy and safety as a once-daily treatment for type 2 diabetes.http://www.apria.com/resources/1,2725,494-857391,00.htmlBristol Myers Squibb Companyhttp://www.imclone.com/other.phpDestination Access Destination Access was created by Bristol-Myers Squibb to improve access to care for cancer patients receiving Bristol-Myers Squibb Oncology products and to help community-based oncology practices secure payment for patients' medicines within payer guidelines.http://www.imclone.com/other.phpBristol Myers Squibb Companyhttp://www.avigen.com/boardofdirectors.phpZola Horovitz, Ph.D., Chairman of the Board, has served as a director of Avigen since November 1994. Dr. Horovitz has been an independent consultant to pharmaceutical and biotechnology companies since May 1994. From 1991 to May 1994, Dr.http://www.avigen.com/boardofdirectors.phpBristol Myers Squibb Companyhttp://www.focusonthefuture.net/speakers.htmlDuring his 14 years at General Mills, Bellairs has led a number of R&D initiatives in the company’s meals, Big G cereal and innovation groups. Prior to joining General Mills, Bellairs worked in R&D for the Campbell Soup Co., ConAgra Foods and Mars Inc.http://www.focusonthefuture.net/speakers.htmlBristol Myers Squibb Companyhttp://www.clearviewprojects.com/management.htmlKenneth Weg, Chairman and a Founder of Clearview Projects, had over 33 years of leadership experience in the pharmaceutical industry with Merck, Sharp & Dohme and Bristol-Myers Squibb Prior to the formation of Clearview.http://www.clearviewprojects.com/management.htmlBristol Myers Squibb Companyhttp://www.fms-inc.com/Applications/Automated%20Enzyme%20Hudrolysis%20latest.htm“When we contacted the manufacturer to purchase new systems we found they had discontinued our old system and now offered a newer series at roughly twice the price.http://www.fms-inc.com/Applications/Automated%20Enzyme%20Hudrolysis%20latest.htmBristol Myers Squibb Companyhttp://www.taconic.com/news-press/Artemis_BMS.htmCologne, February 28, 2006 --- Artemis Pharmaceuticals GmbH announced today it has signed a target validation collaboration agreement with Bristol-Myers Squibb Company. Under the agreement Artemis will generate various genetically-engineered murine models carrying selected genetic mutations.http://www.taconic.com/news-press/Artemis_BMS.htmBristol Myers Squibb Companyhttp://www.drugs.com/nda/pargluva_050909.htmlDrugs.com - prescription drug and over the counter medicine information available on over 24,000 approved medications and pharmaceuticals, including side effects and drug interactions.http://www.drugs.com/nda/pargluva_050909.htmlBristol Myers Squibb Companyhttp://www.countrydoctor.co.uk/precis/precis%20-%20Pharma's%20woes.htmEli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi-Aventis, Schering-Plough, Takeda and Wyeth.http://www.countrydoctor.co.uk/precis/precis%20-%20Pharma's%20woes.htmBristol Myers Squibb Companyhttp://www.zymogenetics.com/about/management-team.htmlBruce L.A. Carter, Ph.D. Chairman of the Board and Chief Executive Officer Dr. Carter was appointed Chairman of the Board in April 2005. He has been Chief Executive Officer since April 1998. On November 21, 2008, Dr.http://www.zymogenetics.com/about/management-team.htmlBristol Myers Squibb Companyhttp://www.biotk.com/directory_details.php?iden=36Presentation: Exelixis is a leading genomics-based drug discovery company focused on the discovery and development of innovative new drugs for cancer and other major human diseases.http://www.biotk.com/directory_details.php?iden=36Bristol Myers Squibb Companyhttp://www.vcu-cme.com/gaba/accred.htmlListen to Real Audio Round Table Discussion Program Faculty Bruce Lydiard, M.D., Chairman, Director of Southeast Health Consultants, Charleston, SC Mark H. Pollack, M.D.http://www.vcu-cme.com/gaba/accred.htmlBristol Myers Squibb Companyhttp://www.biocon.com/biocon_press_releases_details.asp?Fileid=250Biocon Limited, India's premier biotechnology company today announced that its subsidiary company Syngene has entered into a research partnership with Bristol-Myers Squibb (NYSE: BMY).http://www.biocon.com/biocon_press_releases_details.asp?Fileid=250Bristol Myers Squibb Companyhttp://www.macromed.com/news.asp?ID=10Sandy, UT - February 8, 2001 - MacroMed and Bristol-Myers Squibb (BMS) have entered into a multi-drug Evaluation and Option Agreement allowing BMS access to MacroMed's proprietary solubilization technologies, HySolv and ReSolv .http://www.macromed.com/news.asp?ID=10Bristol Myers Squibb Companyhttp://www.omniomix.com/inthenews.php?id=70166-- Exelixis, Inc. (Nasdaq: EXEL) and Bristol-Myers Squibb Company (NYSE: BMY) today announced a worldwide collaboration to discover, develop and commercialize novel targeted therapies for the treatment of cancer.http://www.omniomix.com/inthenews.php?id=70166Bristol Myers Squibb Companyhttp://www.iconixpharm.com/partners/research_collab.htmlIconix establishes research collaborations and licensing relationships with major pharmaceutical and biotechnology companies in diverse areas of pharmaceutical drug discovery.http://www.iconixpharm.com/partners/research_collab.htmlBristol Myers Squibb Companyhttp://www.healthcareitnews.com/printStory.cms?id=8290The seven-year contract aims at increasing productivity, mitigating risk and lowering operational costs throughout Bristol-Myers Squibb's data centers around the world.http://www.healthcareitnews.com/printStory.cms?id=8290Bristol Myers Squibb Companyhttp://www.newsrx.com/health-alert/2117.htmlKAI-9803 is designed to reduce the size of the heart attack and to improve clinical outcomes during treatment of acute myocardial infarction (AMI). KAI-9803 is expected to enter Phase 2b clinical testing by the end of 2008 in patients with ST elevation myocardial infarction (STEMI).http://www.newsrx.com/health-alert/2117.htmlBristol Myers Squibb Companyhttp://www.lexicongenetics.com/alliances/current-alliances.htmlTo maximize the productivity of our platform technology, we have entered into several research and development collaborations. We have an active alliance management group that focuses on maximizing the value of the assets in any collaboration.http://www.lexicongenetics.com/alliances/current-alliances.htmlBristol Myers Squibb Company